Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 5:00 PM ET

Date/Time Source News Release
06/10/2025 08:05 AM EDT GlobeNewswire Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA(TM) (bevacizumab gamma) for the Treatment of Wet AMD
06/02/2025 07:00 AM EDT GlobeNewswire Outlook Therapeutics® Announces Commercial Launch of LYTENAVA(TM) (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
05/23/2025 06:30 AM EDT GlobeNewswire Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
05/22/2025 04:01 PM EDT GlobeNewswire Outlook Therapeutics® Announces Proposed Public Offering of Common Stock and Warrants
05/15/2025 04:01 PM EDT GlobeNewswire Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
04/08/2025 08:45 AM EDT GlobeNewswire Outlook Therapeutics® Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD
02/28/2025 08:05 AM EST GlobeNewswire Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
02/19/2025 09:00 AM EST GlobeNewswire Outlook Therapeutics® Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
02/14/2025 08:05 AM EST GlobeNewswire Outlook Therapeutics® Reports Financial Results for First Quarter Fiscal Year 2025 and Provides Corporate Update
02/04/2025 09:05 AM EST GlobeNewswire Outlook Therapeutics® Participates in Virtual Investor "What This Means" Segment
Page

Additional News

As of June 14, 2025 • 5:00 PM ET

Date/Time Source News Release
06/04/2025 08:45 AM EDT Financial News Media Innovations in Imaging, such as AI-Enhanced Retinal & Fundus Camera Systems are Booming Along with Revenue Opportunities
05/23/2025 06:48 AM EDT SeekingAlpha Outlook Therapeutics drops 17%, prices $13M stock offering
05/22/2025 04:21 PM EDT SeekingAlpha Outlook Therapeutics announces proposed public offering of common stock, warrants
05/17/2025 05:31 AM EDT US Earnings Reports Expected earnings - Outlook Therapeutics Inc.
05/15/2025 04:35 PM EDT SeekingAlpha Outlook Therapeutics Non-GAAP EPS of -$0.40 beats by $0.15
04/08/2025 10:42 AM EDT SeekingAlpha Outlook Therapeutics gets FDA review acceptance for wet AMD treatment
03/20/2025 05:24 PM EDT SeekingAlpha Outlook Therapeutics files to sell 21.72M shares of common stock for holders
02/28/2025 04:52 PM EST SeekingAlpha Outlook Therapeutics files to sell 7.07M shares of common stock for holders
02/14/2025 09:32 AM EST SeekingAlpha Outlook Therapeutics reports Q1 results
02/12/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Wednesday, February 12th, 2025
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.